Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
| ▸ | PIN4 | Q9Y237 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392707 | 1.00 | PPARG (0.45) | PPARGL3MBTL1KMT2AGSK3AGSK3B | |
| SCHEMBL9936606 | 0.87 | TNF (0.43) | PPARGL3MBTL1TSHRCA12CA1 | |
| SCHEMBL9968847 | 0.86 | L3MBTL1 (0.41) | PPARGL3MBTL1KMT2ATSHRMEN1 | |
| SCHEMBL29390952 | 0.86 | L3MBTL1 (0.41) | PPARGL3MBTL1KMT2ATSHRMEN1 | |
| SCHEMBL9938468 | 0.83 | TSHR (0.56) | L3MBTL1KMT2ATSHRMEN1USP2 | |
| SCHEMBL9937177 | 0.83 | L3MBTL1 (0.40) | L3MBTL1KMT2ATSHRMEN1HTT | |
| SCHEMBL15328838 | 0.82 | TSHR (0.43) | L3MBTL1KMT2ATSHRMEN1RAB9A | |
| SCHEMBL9938471 | 0.81 | CYP19A1 (0.41) | L3MBTL1KMT2AGAATSHRMEN1 | |
| SCHEMBL9968851 | 0.81 | ALDH1A1 (0.41) | L3MBTL1KMT2AGAATSHRMEN1 | |
| SCHEMBL15341257 | 0.81 | TYR (0.40) | L3MBTL1KMT2ATSHRMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3393603-B1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INGREDIENTS | OREAL (FR) | 2023-01-18 | — | — | EP | disclosed |
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | L'OREAL (FR) | 2021-10-26 | — | — | US | disclosed |
| WO-2017110151-A1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INGREDIENTS | L'OREAL (FR) | 2017-06-29 | — | — | WO | disclosed |
| US-20170087064-A1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | L'OREAL (FR) | 2017-03-30 | — | — | US | disclosed |
| US-20170087064-A1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | L'OREAL (FR) | 2017-03-30 | — | — | US | disclosed |
| WO-2015198922-A1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | L'OREAL (FR) | 2015-12-30 | — | — | WO | disclosed |
| EP-2651886-B1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | ORÉAL L (FR) | 2015-03-04 | — | — | EP | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| WO-2012079938-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | NQO1, LRAT, RBP4 | PPARG 396/4885L3MBTL1 3046/4885KMT2A 1778/4885 |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | KRT18, KLHL20, IK | PPARG 4187/4885L3MBTL1 4589/4885KMT2A 144/4885 |
| US-20170087064-A1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | LRAT, LIPA, DAGLA | PPARG 375/4885L3MBTL1 3662/4885KMT2A 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.